Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading
-
General24 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
General8 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism
-
Noosa News14 hours agoInside the big change in homebuyer habits during the Christmas holidays
-
Noosa News8 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified